103 Results (Page 1 of 9)
France Markets Research Reports
France Diabetes Devices Market Analysis
The France Diabetes Devices Market is expected to witness growth from $625 Mn in 2022 to $1011 Mn in 2030 with a CAGR of 6.20% for the forecasted year 2022-2030. In France, insulin pumps have become increasingly popular due to their ability to improve glycemic control and enhance the quality of life for diabetes patients in France. Manufacturers that offer insulin pumps with advanced features and better usability are likely to see growth in the market. The market is segmented by type and by the end user. Some key players in this market include Nanosonics France, SAMMEX Medical, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.
France Cardiac Surgery Instruments Market Analysis
The France Cardiac Surgery Instruments Market is expected to witness growth from $57 Mn in 2022 to $88 Mn in 2030 with a CAGR of 5.60% for the forecasted year 2022-2030. The market for heart surgical devices in France is expanding as less invasive techniques become more popular. Because they are less intrusive, these procedures have quicker recovery periods and fewer complications, which is encouraging both patients and healthcare professionals to use them more frequently. The market is segmented by type, application and by end user. Some key players in this market include Delacroix-Chevalier, Marquat, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
France Cardiovascular Diseases Therapeutics Market Analysis
France's cardiovascular disease therapeutics market is projected to grow from $4.47 Bn in 2022 to $7.24 Bn in 2030 with a CAGR of 6.22% for the year 2022-2030. The rising prevalence of cardiovascular diseases in France and consequently increased healthcare spending in France are the major market drivers for the growth of the market. The France cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Medac, Laboratoires Boiron, and AstraZeneca are the major players in the France cardiovascular disease therapeutics market.
France Anti Aging Therapeutics Market Analysis
France anti-aging therapeutics market is expected to witness growth from $17 Mn in 2022 to $53 Mn in 2030 with a CAGR of 15.53% for the year 2022-2030. The presence of robust research and development industry in France makes it a popular destination for the testing of anti-aging therapeutics thereby resulting in the growth of the market. The France anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the key players in the market include Cottos, DBV Technologies, and Allergan.
France Healthcare Claims Management Market Analysis
The France healthcare claims management market is projected to grow from $734.25 Mn in 2022 to $3699.09 Mn by 2030, registering a CAGR of 22.4% during the forecast period of 2022 - 2030. The main factors driving the growth would be increasing healthcare spending, government initiatives, the ageing population and increasing privatization. The market is segmented by component, type, by delivery mode and end-user. Some of the major players include Almerys, Cegedim, Prima Solutions, Accenture, Cognizant and Genpact.
France Artificial Intelligence (AI) in Healthcare Market Analysis
France's Artificial Intelligence (AI) in the healthcare market is projected to grow from $0.19 Bn in 2022 to $3.55 Bn by 2030, registering a CAGR of 44.22% during the forecast period of 2022-30. The market will be driven by the increasing healthcare demands and the strong healthcare system of France. The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, Therapixel & Moon Surgical.
France Healthcare Insurance Market Analysis
The France healthcare insurance market is projected to grow from $55.72 Bn in 2022 to $92.91 Bn by 2030, registering a CAGR of 6.6% during the forecast period of 2022 - 2030. The main factors driving the growth would be government support, the ageing population, technological innovation, increased awareness and demand for healthcare insurance. The market is segmented by component, provider, coverage, by health insurance plans and end-user. Some of the major players include Credit Agricole, Groupama, Harmonie Mutuelle, CNP and MGEN.
France ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
France's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to grow from $813 Mn in 2022 to $1,345 Mn in 2030 with a CAGR of 6.5% for the year 2022-30. The increased prevalence of ADHD in France and rising investments in mental health services are the major market drivers for the growth of the market. The France ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Novasep, Poxel, and Adlon Therapeutics are the key players in the market.
France Oncology Clinical Trials Market Analysis
The France oncology clinical trials market is projected to grow from $347.9 Mn in 2022 to $494.7 Mn by 2030, registering a CAGR of 4.5% during the forecast period of 2022-30. The market will be driven by the rising prevalence of cancer cases, the modern healthcare system in the nation, and a supportive regulatory framework. The market is segmented by phase, by study design & by indication. Some of the major players include Roche Holding AG, Transgene & Ipsen.
France Oral Care Market Analysis
The France Oral Care market was valued at $969 Mn in 2022 and is estimated to expand at a CAGR of 5.2% from 2022 to 2030 and will reach $1453 Mn in 2030. One of the main reasons propelling the growth of this market is E-commerce Growth, aging population. The market is segmented by type, drug and distribution channel. Some key players in this market are Pierre Fabre Oral Care, GUM, Laboratoires Septodont, Elgydium, Biotech Dental, 3M, Carestream Dental, Periosystem among others.
France Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the France Liver Disease Therapeutics market will reach a value of $917 Mn from $635 Mn in 2022, growing at a CAGR of 4.7% during 2022-2030. Liver Disease Therapeutics in France is dominated by a few domestic pharmaceutical companies such as Genfit, Sanofi, and Inventiva. The Liver Disease Therapeutics market in France is segmented into different types of disease and different therapy types. Some of the major factors affecting the France Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
France Multiple Myeloma Therapeutics Market Analysis
The France Multiple Myeloma Therapeutics Market was valued at $229 Mn in 2022 and is estimated to expand at a CAGR of 3.5% from 2022 to 2030 and will reach $302 Mn in 2030. In One of the main reasons propelling the growth of this Market is Government initiatives and funding, aging population. The Market is segmented by type, drug and distribution channel. Some key players in this Market are Onxeo, Nanobiotix, AB Science, Servier, Sigma Aldrich and others.
France Diabetes Drugs Market Analysis
The France diabetes drugs market size was valued at $1.69 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.1% from 2022 to 2030 and will reach $2.52 Bn in 2030. The market is segmented by drug type, application, and distribution channel. The France diabetes drug market will grow because there is a growing focus on preventive measures to reduce the risk of developing diabetes, including lifestyle changes, which is also driving the demand for diabetes management products and services. The key market players are Adocia (FRA), Voluntis (FRA), Biocorp (FRA), CERBA HealthCare (FRA), Boehringer Ingelheim, Sanofi, and others.
France Robotic Surgery Services Market Analysis
France's robotic surgery service market size was valued at $118 Mn in 2022 and is estimated to expand at a CAGR of 18.3% from 2022-30 and will reach $453 Mn in 2030. The robotic surgery service market will grow due to the development of new and improved robotic surgical systems is making these procedures more accessible and affordable, and helping to increase awareness about their benefits among healthcare providers and patients. The market is segmented by product and service type, application type, and end user. Some of the major players are Medtronic, Johnson & Johnson, Stryker, Intuitive Surgical, Smith & Nephewand others
France Connected Healthcare Market Analysis
The France-connected healthcare market is projected to grow from $1.83 Bn in 2022 to $12.67 Bn by 2030, registering a CAGR of 27.4% during the forecast period of 2022 - 2030. The main factors driving the growth would be government support, health tech startups and the rising geriatric population. The market is segmented by type, function and by application. Some of the major players include Sanofi, Withings, Voluntis, Evolucare, Apple, Microsoft, Siemens Healthineers and Medtronic.
France Artificial Intelligence (AI) in Medical Imaging Market Analysis
France artificial intelligence (AI) in medical Imaging market size was valued at $41 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 34.4% from 2022 to 2030 and will reach $439 Mn. The market is segmented by AI technology, solution, modality, application, and end User. Due to developments in AI and machine learning algorithms that are enabling the creation of more precise and effective medical imaging software, the France Artificial Intelligence (AI) in the Medical Imaging market will expand. Some of the key players in this market are KineQuantum, Quantificare, Median Technologies, Mirada Medical, CureMetrix, Olea Medical, Aidence, Smart Reporting, CorTechs Labs, and others, and others.
France Primary Hyperoxaluria (PH) Therapeutics Market Analysis
The France Primary Hyperoxaluria (PH) Therapeutics market was valued at $XX Bn in 2022 and is estimated to expand at a CAGR of 3.8% from 2022 to 2030 and will reach $XX Bn in 2030. One of the main reasons propelling the growth of this market is increase in awareness, aging population. The market is segmented by diagnostic method, by treatment, by type. Some key players in this market Sanofi Genzyme, Ox Thera, Dicerna Pharmaceuticals, AGC Biologics, Sernova among others.
France Neurology Clinical Trials Market Analysis
The France Neurology Clinical Trials market is projected to grow from $279.3 Mn in 2022 to $371.1 Mn by 2030, registering a CAGR of 3.62% during the forecast period of 2022 - 2030. The market will be driven by the growing frequency of neurological diseases and the robust research infrastructure of France. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis International AG, Sanofi SA & Neuraxpharm France SAS.
France 3D Printing Medical Devices Market Analysis
The France 3D Printing Medical Devices market size was valued at $82 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 15.3% from 2022 to 2030 and reach $255 Mn in 2030. The market is segmented by component, application, , technology, and end user. The 3D-printed medical devices market in France will grow as the development of new 3D printing materials and techniques leads to the production of more complex and customizable medical devices. The key market players are AnatomikModeling, EOS, Impression 3D Médicale, InSimo, OsseoMatrix, Poietis, and SpineVisionare, among others.
France Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Analysis
The France COPD Therapeutics Market was valued at $502 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.1% from 2022 to 2030 and will reach $806 Mn in 2030. One of the main reasons propelling the growth of this market is increase prevalence rate, Aging population. The market is segmented by Drug class and By distribution channel. Some key players in this market are Salt Med, Adamis Pharmaceuticals Corporation, Almirall, Astellas Pharma, American hospital of Paris, Boehringer Ingelheim Pharmaceuticals, Novartis, Pfizer, and others.
France Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the France infectious disease therapeutics market will reach a value of $4.29 Bn from $3.3 Bn in 2022, growing at a CAGR of 3.4% during 2022-2030. The Infectious Disease Therapeutics in France is dominated by a few domestic pharmaceutical companies such as BioMérieux, Sanofi and Institut Mérieux. The Infectious Disease Therapeutics market in France is segmented into different therapeutic areas and different diseases type. The major factors affecting the France infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the lack of healthcare funding for infectious diseases treatment in various areas of France.
France Clinical Diagnostics Market Analysis
France's clinical diagnostic market was valued at $1.9 Bn in 2022 and is estimated to expand at a CAGR of 5% from 2022-30 and will reach $2.8 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and advancement in technology. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, BD, bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, Siemens AG, Hologic, Qiagen NV, Quest Diagnostics, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Sysmex, Diaxonhit, Eurofins Scientific, Genomic Vision, Stago, and others.
France Neurology Devices Market Analysis
France's neurology device market size is at around $347.05 Mn in 2022 and is projected to reach $587.44 Mn in 2030, exhibiting a CAGR of 6.8% during the forecast period. France has a high burden of neurology illnesses, and businesses such as Cerveau Technologies, In Vivo Neurotech, and NeuroMed Technologie dominate the market. This report by Insights10 is segmented by product type like neurostimulation, interventional neurology, neurosurgery devices, and neuro-endoscopes, and by the end user.
France Acne Therapeutics Market Analysis
France's acne therapeutics market is expected to witness growth from $276 Mn in 2022 to $430 Mn in 2030 with a CAGR of 5.7% for the forecast year 2022-2030. The rising demand for acne medications for the acne increasing incidence of acne in France is the major market driver for the market. The France acne therapeutics market is segmented by treatment, route of administration, age group, and distribution channel. Some of the key competitors in the market are Pierre Fabre, Ceva Santé Animale, and Teva Pharmaceuticals.
France Patient Engagement Solutions Market Analysis
The France patient engagement solutions market is projected to grow from $467.78 Mn in 2022 to $1093.64 Mn by 2030, registering a CAGR of 11.2% during the forecast period of 2022 - 2030. The main factors driving the growth would be the ageing population, rising demand for patient-centred care, technological advancements and government support. The market is segmented by component, delivery mode, application, therapeutic area, functionality and by end-user. Some of the major players include Doctolib, Keldoc, Medaviz, Mckesson and Lincor.